πŸ‡ΊπŸ‡Έ FDA
Patent

US 9562020

Dihydroxy aromatic heterocyclic compound

granted A61KA61K31/4412A61K31/4418

Quick answer

US patent 9562020 (Dihydroxy aromatic heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Feb 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/4412, A61K31/4418, A61K31/4427, A61K31/443